Neuroscience Daily for 26 September covers 3 neuroscience stories on southern europe neurotech, epilepsy astrocytes, amygdala cell map. It is a compact audio briefing on studies, mechanisms, and the discussion around them.
Neuroscience Daily for 26 September follows 3 stories from r/neuro and r/neuroscience, moving through southern europe neurotech, epilepsy astrocytes, amygdala cell map.
The first story is a new map of neurotechnology companies in Spain, Portugal, and Italy, shared through the Neurotech Newsletter. The survey counts 63 selected core and enabling companies, spanning brain-computer interfaces, biosignals, neurorehabilitation, assistive robotics, and clinical tools.
The second story comes from Berkeley News, covering a Nature study of childhood epilepsy linked to tuberous sclerosis complex. Researchers grew human brain organoids carrying mutations in the TSC2 gene and found that astrocytes became hyperreactive as they developed, with gene and protein patterns associated with inflammation.
The third story is a bioRxiv preprint titled The work uses spatial transcriptomics to connect gene-expression patterns with the physical organization of cells across the human amygdala. That matters because the amygdala is often discussed as a single fear and emotion center, even though its subregions contain distinct cell populations and circuits.
Episode closing.
The most talked-about neuroscience discoveries, studies and breakthroughs, distilled into a five-minute daily briefing. From brain health and cognition to sleep, memory and consciousness, stay on top of the research shaping how we understand the mind.